Physician

Ashok M. Parmar, M.D.

According to 2025 Medicare claims, Ashok Parmar, M.D. (NPI: 1164419073) practices pain management in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is UNIVERSAL HEALTHCARE SERVICES INC. (NPI: 1720282585; TIN: 71-1031193) and primary practice location at 93301-1645.

Parmar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,795 traditional Medicare patients, billed 19,356 HCPCS/CPT codes, and received $966,178 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 9,058 prescription claims across 1,880 beneficiaries totaling $259,242 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2022 DME data shows 21 claims. Open Payments data shows 18 records totaling $402. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $642,939 to $966,178. In contrast, Part D prescription costs have fallen sharply in recent years, from $554,466 to $259,242. For DME billing, this smaller-volume category moved sharply higher in recent years, from $0 to $2,635.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	916	15,662	$642,939
2016	923	6,028	$438,011
2017	1,176	12,190	$778,756
2018	1,302	13,575	$880,680
2019	1,446	10,333	$750,512
2020	1,590	10,480	$818,704
2021	3,195	12,227	$883,162
2022	1,921	11,791	$1,007,397
2023	1,690	10,382	$819,615
2024	1,795	19,356	$966,178

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,244	9,363	$554,466
2016	1,596	14,362	$828,262
2017	1,871	18,946	$993,720
2018	1,544	15,366	$854,692
2019	1,460	8,452	$486,776
2020	1,640	9,060	$471,883
2021	1,583	8,114	$325,169
2022	1,524	6,185	$238,302
2023	1,460	6,254	$279,265
2024	1,880	9,058	$259,242

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	153	155	$116,369
2016	192	192	$143,302
2017	243	244	$180,243
2018	249	249	$183,622
2019	337	351	$234,601
2020	158	160	$102,945
2021	56	68	$26,680
2022	N/R	21	$228
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	427	735	$195
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,229	3,912	$82
80307	Testing for presence of drug, by chemistry analyzers	510	754	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	778	1,847	$60
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	575	1,249	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	3,679	105,482	$78,903
Ztlido	Lidocaine	81	2,400	$43,758
Lidocaine	Lidocaine	213	6,195	$22,773
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	523	15,218	$17,936
Buprenorphine	Buprenorphine	64	1,721	$12,194

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$402	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashok M. Parmar, M.D.?

Tedicare shows public-source Medicare data for Ashok M. Parmar, M.D. (NPI 1164419073), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashok M. Parmar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ashok M. Parmar, M.D.?

Ashok M. Parmar, M.D. is linked to UNIVERSAL HEALTHCARE SERVICES INC. (billing NPI 1720282585) in the available physician profile data.

Does Ashok M. Parmar, M.D. have Open Payments data?

Ashok M. Parmar, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.